Yip Wanfen, Sabanayagam Charumathi, Ong Peng Guan, Patel Uptal D, Chow Khuan Yew, Tai E Shyong, Ling Lieng H, Wong Tien Yin, Cheung Carol Yim-Lui
Singapore Eye Research Institute, Singapore National Eye Centre, Singapore.
Department of Ophthalmology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore.
Sci Rep. 2016 Jun 8;6:27442. doi: 10.1038/srep27442.
Microalbuminuria is associated with an increased risk of cardiovascular disease (CVD), but not all individuals require treatment. Retinal microvascular abnormalities and microalbuminuria reflect early systemic microvascular changes. We examined the joint effect of retinal abnormalities and microalbuminuria on CVD risk in an Asian cohort. We conducted a prospective, population-based study. Retinal abnormalities were defined as presence of retinopathy and/or retinal venular widening. Microalbuminuria was defined as urinary albumin: creatinine ratio between 30-300 mg/g. Incident CVD was defined as newly diagnosed clinical stroke, acute myocardial infarction or CVD death. Cox regression models were performed to determine the associations between retinal abnormalities and microalbuminuria with risk of CVD, while controlling for established risk factors. 3,496 participants (aged ≥ 40) were free of prevalent CVD. During the follow-up (5.8 years), 126 (3.60%) participants developed CVD. Persons presenting with both retinal abnormalities and microalbuminuria were 6.71 times (95% CI, 2.68, 16.79) as likely to have incident CVD compared with those without either abnormalities. There was a significant interaction effect between retinal abnormalities and microalbuminuria on incident CVD. Assessment of retinal abnormalities in patients with microalbuminuria may provide additional value in identifying persons at risk of developing CVD.
微量白蛋白尿与心血管疾病(CVD)风险增加相关,但并非所有个体都需要治疗。视网膜微血管异常和微量白蛋白尿反映了早期全身性微血管变化。我们在一个亚洲队列中研究了视网膜异常和微量白蛋白尿对CVD风险的联合影响。我们进行了一项基于人群的前瞻性研究。视网膜异常定义为存在视网膜病变和/或视网膜静脉增宽。微量白蛋白尿定义为尿白蛋白:肌酐比值在30 - 300mg/g之间。新发CVD定义为新诊断的临床中风、急性心肌梗死或CVD死亡。在控制既定风险因素的同时,采用Cox回归模型来确定视网膜异常和微量白蛋白尿与CVD风险之间的关联。3496名参与者(年龄≥40岁)无CVD病史。在随访期间(5.8年),126名(3.60%)参与者发生了CVD。与无任何异常的人相比,同时存在视网膜异常和微量白蛋白尿的人发生新发CVD的可能性是其6.71倍(95%CI,2.68,16.79)。视网膜异常和微量白蛋白尿对新发CVD存在显著的交互作用。对微量白蛋白尿患者进行视网膜异常评估可能在识别有发生CVD风险的人群方面提供额外价值。